Literature DB >> 12845671

N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation.

Yanchun Deng1, Libo Yao, Ling Chau, Samuel Sai-ming Ng, Ying Peng, Xinping Liu, Wo-shing Au, Jicun Wang, Fuyang Li, Shaoping Ji, Hua Han, Xiaoyan Nie, Qing Li, Hsiang-fu Kung, Suet-yi Leung, Marie Chia-mi Lin.   

Abstract

The most severe form of brain glioma, glioblastoma (GBM), is highly malignant and usually resistant to chemotherapy. Therefore, discovery of new targets for gene therapy is important. Using subtraction cloning, we identified the human N-Myc downstream-regulated gene 2 (hNDRG2), located at chromosome 14q11.2, as a gene that is significantly suppressed in GBM tissues. Semiquantitative RT-PCR showed that the hNDRG2 gene transcript is expressed in normal brain tissue and low-grade gliomas but is present at low levels in 15 of 27 (56%) human GBM tissues and all of the 6 human glioblastoma cell lines examined. Furthermore, transfection of human glioblastoma U373 and U138 cells with a cDNA encoding hNDRG2 markedly reduced the cell proliferation. Our findings provide the first evidence to suggest that hNDRG2 may play a role in glioblastoma carcinogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845671     DOI: 10.1002/ijc.11228

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  87 in total

1.  Ndrg2 expression in neurogenic germinal zones of embryonic and postnatal mouse brain.

Authors:  Lijuan Liu; Ming Shi; Li Wang; Shuangxing Hou; Zhongliang Wu; Gang Zhao; Yanchun Deng
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

2.  Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.

Authors:  Wei Lin; Xiao-Ming Li; Jing Zhang; Yi Huang; Jiang Wang; Jian Zhang; Xiao-Fan Jiang; Zhou Fei
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

3.  Neuroprotective Influence of miR-301a Inhibition in Experimental Cerebral Ischemia/Reperfusion Rat Models Through Targeting NDRG2.

Authors:  Tao Feng; Bang-Hua Han; Gong-Li Yang; Chao-Jie Shi; Zhen-Wen Gao; Ming-Zhi Cao; Xiao-Lei Zhu
Journal:  J Mol Neurosci       Date:  2019-03-20       Impact factor: 3.444

4.  NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.

Authors:  Chuigong Yu; Guojun Wu; Ruixiao Li; Lei Gao; Fan Yang; Yi Zhao; Jian Zhang; Rui Zhang; Jing Zhang; Libo Yao; Jianlin Yuan; Xia Li
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  NDRG2 is expressed on enteric glia and altered in conditions of inflammation and oxygen glucose deprivation/reoxygenation.

Authors:  Yuxin Zhang; Hui Gao; Na Li; Haiqing Chang; Bo Cheng; Yansong Li; Jiwen Miao; Shuang Li; Qiang Wang
Journal:  J Mol Histol       Date:  2020-11-17       Impact factor: 2.611

6.  Mass spectrometrical characterization of NDRG2 protein (N-myc-downstream regulated gene 2) and description of two novel phosphorylation sites.

Authors:  Wei-Qiang Chen; Harald Hoeger; Wei-Fei Diao; Arnold Pollak; Gert Lubec
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

7.  Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.

Authors:  Peyman Karimi Goudarzi; Farzad Mehrabi; Reza Jalili Khoshnood; Ali Baradaran Bagheri; Koorosh Ahmadi; Emad Yahaghi; Hesam Abdolhoseinpour
Journal:  Tumour Biol       Date:  2015-11-30

8.  Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes.

Authors:  Anna Mordalska; Joanna Latek; Tomasz Ferenc; Lech Pomorski; Elzbieta Gałecka; Arkadiusz Zygmunt; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2010-08-30

9.  NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.

Authors:  Jian-Jun Ma; Cheng-Gong Liao; Xue Jiang; Hua-Dong Zhao; Li-Bo Yao; Ting-Yi Bao
Journal:  J Exp Clin Cancer Res       Date:  2010-07-30

10.  NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Authors:  Young-Jun Kim; Sun Y Yoon; Jong-Tae Kim; Eun Y Song; Hee G Lee; Hyun J Son; Soo Y Kim; Daeho Cho; Inpyo Choi; Joo H Kim; Jae W Kim
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.